Incidence of ischaemic stroke and mortality in patients with acute coronary syndrome and first-time detected atrial fibrillation: a nationwide study

European Heart Journal

3 September 2021
Organised by: Logo
ESC Journals ARRHYTHMIAS AND DEVICE THERAPY CORONARY ARTERY DISEASE, ACUTE CORONARY SYNDROMES, ACUTE CARDIAC CARE DISEASES OF THE AORTA, PERIPHERAL VASCULAR DISEASE, STROKE Stroke Atrial Fibrillation (AF) PREVENTIVE CARDIOLOGY Risk Factors and Prevention BASIC SCIENCE BASICS

Abstract

AbstractAims 

The aim of this study was to examine contemporary data on the 1-year prognosis of patients surviving acute coronary syndrome (ACS) and concomitant first-time detected atrial fibrillation (AF).

Methods and results

Using Danish nationwide registries, we identified all patients surviving a first-time admission with ACS from 2000 to 2018 and grouped them into (i) those without AF prior to or during ACS; (ii) those with a history of AF; and (iii) those with first-time detected AF during admission with ACS. With 1 year of follow-up, rates of ischaemic stroke, death, and bleeding were compared between study groups using multivariable adjusted Cox proportional hazards analysis. We included 161 266 ACS survivors: 135 878 (84.2%) without AF, 18 961 (11.8%) with history of AF, and 6427 (4.0%) with first-time detected AF at admission with ACS. Compared to those without AF, the adjusted 1-year rates of outcomes were as follows: ischaemic stroke [hazard ratio (HR) 1.38 (95% CI 1.22–1.56) for patients with history of AF and HR 1.67 (95% CI 1.38–2.01) for patients with first-time detected AF]; mortality [HR 1.25 (95% CI 1.21–1.31) for patients with history of AF and HR 1.52 (95% CI 1.43–1.62) for patients with first-time detected AF]; and bleeding [HR 1.22 (95% CI 1.14–1.30) for patients with history of AF and HR 1.28 (95% CI 1.15–1.43) for patients with first-time detected AF].

Conclusion 

In patients with ACS, first-time detected AF appeared to be at least as strongly associated with the 1-year rates of ischaemic stroke, mortality, and bleeding as compared with patients with a history of AF.

Contributors

Jeppe Kofoed Petersen
Jeppe Kofoed Petersen

Author

Rigshospitalet - Copenhagen University Hospital Copenhagen , Denmark

Adelina Yafasova
Adelina Yafasova

Author

Rigshospitalet - Copenhagen University Hospital Copenhagen , Denmark

Christian Torp-Pedersen
Christian Torp-Pedersen

Author

Nordsjaellands Hospital Hilleroed , Denmark

Rikke Sørensen
Rikke Sørensen

Author

Rigshospitalet - Copenhagen University Hospital Copenhagen , Denmark

Naja Emborg Vinding
Naja Emborg Vinding

Author

Rigshospitalet - Copenhagen University Hospital Copenhagen , Denmark

Lars Køber
Lars Køber

Author

Rigshospitalet - Copenhagen University Hospital Copenhagen , Denmark

ESC 365 is supported by